Eduardo Novoa Cianelli

Eduardo Novoa Cianelli practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Eduardo Novoa Cianelli's NPI, 1992302756, was assigned on October 5, 2020. Eduardo Novoa Cianelli holds Florida license APRN11009253.

Eduardo Novoa Cianelli's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Eduardo Novoa Cianelli's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Eduardo Novoa Cianelli practices. Vendor and product names are available with a free account.

Nurse practitioner is Eduardo Novoa Cianelli's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Eduardo Novoa Cianelli is licensed in Florida.

CMS data shows 17 Medicare services from Eduardo Novoa Cianelli across 1 procedure code in 2024, all of them office visits, for 37 Medicare patients. Medicare paid $1,659 for them. Every service was in an office.

CMS counts 37 Medicare patients who saw Eduardo Novoa Cianelli in 2024. The largest group is 65 to 74, with 13 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 54% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Eduardo Novoa Cianelli's median patient age at 56, with 68% women.

In 2024, Eduardo Novoa Cianelli wrote 76 Medicare Part D claims for 31 patients. 39% of them were for generic drugs. CMS names the drug for 54 of them, across 2 drugs with 11 or more claims each, at $42,917 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Eduardo Novoa Cianelli for performance year 2024, reported as part of a group. Eduardo Novoa Cianelli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Eduardo Novoa Cianelli as offering telehealth.

CMS Open Payments shows 22 general payments to Eduardo Novoa Cianelli from 12 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $267.